A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice
Oncotarget · 2024
DOI: 10.18632/oncotarget.28638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2024. Verfasst von Zhen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA. Hauptthemen laut MEDLINE: Vacuolar Proton-Translocating ATPases, Single-Domain Antibodies, Lung Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump that functions to control the pH of intracellular compartments as well as to transport protons across the plasma membrane of various cell types, including cancer cells. We have previously shown that selective inhibition of plasma membrane V-ATPases in breast tumor cells inhibits the invasion of these cells in vitro. We have now developed a nanobody directed against an extracellular epitope of the mouse V-ATPase c subunit. We show that treatment of 4T1-12B mouse breast cancer cells with this nanobody inhibits V-ATPase-dependent acidification of the media and invasion of these cells in vitro. We further find that injection of this nanobody into mice implanted with 4T1-12B cells orthotopically in the mammary fat pad inhibits metastasis of tumor cells to lung. These results suggest that plasma membrane V-ATPases represent a novel therapeutic target to limit breast cancer metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA.
- Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
- Department of Pharmacology, University of Minnesota School of Medicine, MN 55455, USA.
- Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
- Department of Developmental, Molecular, and Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA.
- Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Li, Z., Alshagawi, M. A., Oot, R. A., Alamoudi, M. K., Su, K., Li, W., Collins, M. P., Wilkens, S., & Forgac, M. (2024). A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice. Oncotarget. https://doi.org/10.18632/oncotarget.28638
Vancouver
Li Z, Alshagawi MA, Oot RA, Alamoudi MK, Su K, Li W, et al. A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice. Oncotarget. 2024. doi:10.18632/oncotarget.28638
BibTeX
@article{Li2024,
author = {Li, Zhen and Alshagawi, Mohammed A and Oot, Rebecca A and Alamoudi, Mariam K and Su, Kevin and Li, Wenhui and Collins, Michael P and Wilkens, Stephan and Forgac, Michael},
title = {A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice},
journal = {Oncotarget},
year = {2024},
doi = {10.18632/oncotarget.28638}
}
EUVIMED